VC Dealflow: Oct. 25, 2007

CamSemi

Fabless semiconductor company Cambridge Semiconductor Ltd. of Cambridge, England, has raised £13 million ($26 million) in Series C funding. 3i Group plc of London led the round, joined by existing U.K.-based shareholders Scottish Equity Partners and TTP Ventures. Also participating was new investor Carbon Trust with a $4 million equity investment. CamSemi is developing integrated circuits that will allow manufacturers to introduce mains-connected converters and battery chargers that are smaller, cheaper and more power efficient. -- G.W.

Software

Interactive Supercomputing

Interactive Supercomputing Inc. has received $11 million in a financing led by new investor Ascent Venture Partners of Boston. Also participating were Fletcher Spaght Ventures of Boston and current investors Flagship Ventures of Cambridge, Mass., and Rock Maple Ventures and CommonAngels, both of Boston. The new round brings ISC's total funding to $18 million. The new financing allows ISC to extend its software into new markets and support additional technical computing languages and libraries. Star-P enables scientists, engineers and analysts to build algorithms and models on their desktops using familiar mathematical tools such as Matlab, Python and R, then run them on parallel computers with little to no modification. -- G.W.

Xencor

Xencor Inc. of Monrovia, Calif., raised $15 million in a second close of a $60 million Series E funding, landing Boston-based Oxford Bioscience Partners and New York's Merlin Nexus as new investors to support a refigured schedule of preclinical and clinical monoclonal antibody development programs. The deal follows an initial close of $45 million a year ago in what was essentially the seven-year-old company's first round of professional venture capital. The company landed MedImmune Ventures Inc. of Gaithersburg, Md., as lead investor in that close, along with other new investors Novo Nordisk of Denmark and HealthCare Ventures of Boston, as well as Zen Investments and other funds affiliated with Chicago-trading magnate John Stafford. The new capital will allow the company to begin clinical trials of its first drug candidate to treat Hodgkin's disease and T-cell lymphoma. It is also expected to allow the company to produce clinical results within 12 months, which investors hope will validate not only its lead product, but also an underlying platform technology that could produce numerous products for treating a variety of cancers and autoimmune diseases. -- Clifford Carlsen

mFoundry

Mobile banking and payment services software developer mFoundry of Sausalito, Calif., raised $15 million in a Series C round of venture capital led by Motorola Ventures in a deal that wraps up partners in a variety of key strategic industries and is expected to take the company to profitability next year. MFoundry recruited the venture arm of Schaumburg, Ill.-based Motorola Inc. based on the parent company's prominent position in the mobile device manufacturing business, but it also opened the round to online payment services leader PayPal Inc. of San Jose, Calif., financial services hardware maker NCR Corp. and an unnamed wireless carrier. The new investment brings total funding to about $25 million and will allow the company to continue to advance its technology while expanding relationships with banks and other financial services organizations. -- C.C.